EDAP appoints Rewcastle as int'l medical director

EDAP TMS of Lyon, France, has appointed John Rewcastle, Ph.D., as international medical director.

Rewcastle's duties will include the company's U.S. clinical trial for Ablatherm, a high-intensity focused ultrasound (HIFU) device for the treatment of prostate cancer.

Most recently, he has worked with cryoablation vendor Endocare of Irvine, CA, in establishing cryoablation as a treatment option for localized prostate cancer.

By AuntMinnie.com staff writers
June 28, 2007

Related Reading

HealthTronics terminates EDAP agreement, April 10, 2007

EDAP TMS to push European marketing efforts, August 4, 2006

EDAP extends Japanese presence, names Laronze as VP, February 16, 2006

EDAP taps Varona as medical director, December 7, 2005

HealthTronics taps new president and CEO, December 5, 2005

Copyright © 2007 AuntMinnie.com

Page 1 of 512
Next Page